Gem Hopkins
Investor Relations Kontakt bei SILENCE THERAPEUTICS PLC
Aktive Positionen von Gem Hopkins
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SILENCE THERAPEUTICS PLC | Investor Relations Kontakt | 01.08.2020 | - |
| Public Communications Contact | 01.08.2020 | - |
Karriereverlauf von Gem Hopkins
Ehemalige bekannte Positionen von Gem Hopkins
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SYNERGY PHARMACEUTICALS INC | Investor Relations Kontakt | - | 01.11.2018 |
Statistik
International
| Vereinigte Staaten | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Investor Relations Contact | 2 |
| Public Communications Contact | 1 |
Sektoral
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SILENCE THERAPEUTICS PLC | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- Gem Hopkins
- Erfahrung
